NCT04478513 - A Study to Assess the Effect of Fluvoxamine and Smoking on Pharmacokinetics ( the Movement of Drugs Within the Body) of AZD4635 in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 21, 2020

Primary Completion Date

December 23, 2020

Study Completion Date

December 23, 2020

Conditions

Healthy Volunteer/DDI Study

Interventions

DRUG

AZD4635

During each treatment period subjects will receive a single dose of AZD4635 under fasting conditions.

DRUG

Fluvoxamine

Daily oral single doses of fluvoxamine are planned to be administered to healthy volunteers in Treatment Period 2.

Trial Locations (1)

Research Site, Harrow